Dr. Saveen Semage re-appointed as CEO of NMRA

The Ministry of Health announced the re-appointment of Dr. Saveen Semage as the new Chief Executive Officer (CEO) of the National Medicines Regulatory Authority (NMRA) today (January 09).
Dr. Saveen Semage previously served as the CEO of the NMRA from November 2021 until May 2022, before he resigned from the position.
In May 2022, Dr. Saveen Semage announced his resignation as the CEO of NMRA on social media, blaming the move by Ravi Kumudesh, President of the College of Medical Laboratory Science, over allegations leveled at NMRA over the drug shortage at that time.
The new appointment was made by Health Minister Dr. Ramesh Pathirana, following a selection process from among applications submitted for the vacant position.
Latest Headlines in Sri Lanka
- Italian Ambassador, Sri Lankan Defence Secretary discuss security ties April 30, 2026
- Oil hits highest price since 2022 as Trump to hear new Iran options April 30, 2026
- India plans new rules as digital payment fraud surges April 30, 2026
- Sri Lanka to set up authority to restore Central Highlands April 30, 2026
- Sri Lanka to launch Colombo Electric Train project next year April 29, 2026
